Parse Biosciences
parsebiosciences.com
Actively hiring
Scientific & Lab Software
Biotechnology
As featured in
View 1 job
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$41.5M
1 round on record
Latest round
$41.5M
Series B · Feb 2022 · 4 yr ago
Team
103
US Form 5500 (plan participants) · Dec 2024
Hiring now
7
+2 posted in 30 days
The money's age
Long since its last round
55 months since the last round · and hiring
Momentum
36/100
hiring for its size, a new city, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 10
Launched Parse Biosciences Launches the Next Generation of its Immune Profiling Kits · morningstar.com
Mar 31
Launched Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis · YahooFinance
May 2, 2024
Launched Parse Biosciences Launches Single Cell Immune Profiling Products · streetinsider.com
Jan 16, 2024
Acquisition Parse Biosciences Acquires Biomage · businesswire.com
Feb 15, 2022
Raised a round Series B $41.5M · businesswire
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Feb 2022 | $41.5M | — | businesswire |
Investors in similar startupsfunds that back the companies most like this one
backs LatchBio
Similar startupsby what they do, their industry and backers
ResearchHub is a collaborative platform for sharing, reviewing, and funding scientific research. Join the open science community.
The intelligent infrastructure for high-scale clinical research at health systems.
The Science Data Cloud. Accelerating scientific progress by making the world.
Silvi is a Copenhagen-based AI company that supports scientific research by speeding up literature reviewing and evidence synthesis. To…
LatchBio is a cloud platform for biological data, giving scientists a place to store sequencing results and run analysis pipelines without…
Advanced single-cell solutions by Atrandi. Discover high-throughput single-cell technologies for genomics, screening, and biological…
News
Funding Large-Scale scRNA-seq Research: A Guide to NIH Grants, Philanthropic Funding, and Industry Partnerships
The post Funding Large-Scale scRNA-seq Research: A Guide to NIH Grants, Philanthropic Funding, and Industry Partnerships appeared first on Parse Biosciences.
Read more
Report
Garvan Institute of Medical Research Joins Parse Biosciences' Certified Service Provider Network
Read more
Report
What Single Cell Analysis, Sulfites, Stem Cells, and Colonoids Reveal About Childhood Colitis: An Interview with Dr Babajide Ojo
The post What Single Cell Analysis, Sulfites, Stem Cells, and Colonoids Reveal About Childhood Colitis: An Interview with Dr Babajide Ojo appeared first on Parse Biosciences.
Read more
Report
FFPE Single Cell Sequencing: Methods, Challenges, and Innovations for Archived Clinical Samples
The post FFPE Single Cell Sequencing: Methods, Challenges, and Innovations for Archived Clinical Samples appeared first on Parse Biosciences.
Read more
Report
Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
SEATTLE, March 31, 2026--Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode Whole Transcriptome FFPE kits that are now shipping
Read more
Report
Why Identical Cells Behave Differently and Why it Matters for Cancer Therapy: scRNA-Seq to Track Transient Drug Tolerance
The post Why Identical Cells Behave Differently and Why it Matters for Cancer Therapy: scRNA-Seq to Track Transient Drug Tolerance appeared first on Parse Biosciences.
Read more
Report
Changes in NIH Funding Policies: A Chat with an NIH Grant Reviewer
The post Changes in NIH Funding Policies: A Chat with an NIH Grant Reviewer appeared first on Parse Biosciences.
Read more
Report
Leading with Compassion and Data: Ethical Science Powered by scRNA-Seq and Non-Animal Models
The post Leading with Compassion and Data: Ethical Science Powered by scRNA-Seq and Non-Animal Models appeared first on Parse Biosciences.
Read more
Report
Reimagining Hematology Research with Single Cell RNA-Seq
The post Reimagining Hematology Research with Single Cell RNA-Seq appeared first on Parse Biosciences.
Read more
Report
Show more news
Salary insights
Compensation ranges based on this company's open jobs
Median
$195k
Typical range
$115k – $270k
Open positions
5
5
Jobs
Junior
40%
Senior
20%
Architect
40%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 2 | $143k | $115k – $170k |
| Senior | 1 | $195k | $195k |
| Architect | 2 | $248k | $225k – $270k |
Highest paying role
Head of Operations
$270k
Normalized to USD per year
All salaries at Parse Biosciences
By role, level and city, against the market · 5 jobs with pay
Growth
Hiring Momentum
62/100
Growing
Open positions
7
1 opened / 1 closed in 30 days
Median time-to-fill
28 days
faster than 43% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Product
25% ▲
Management
25% ▼
Marketing
25% ▲
Sales
13% ▼
Science & Research
13% ▼
Activity Timeline
New location: United States
Oct 2026
Added Microsoft Office to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Seattle
Seattle
United States
HQ
We're your partners in single cell
4 open roles 4 posted in 90 days 25% engineering 25% remote 50-200 est. staff $230k Avg Salary
hires for Product, Management, Science & Research
700 Dexter Ave, Suite 600, Seattle, WA 98109
Jobs
$135k – $195k per year • Remote (United States) • 5+ years exp • Bachelor's Degree • Seattle
Apply
Financials
Total raised
$41.5M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2022 | $41.5M | Details |